Sara B. Capitelli serves as Executive at CASI Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Sara B. Capitelli has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 12, 2018 involved exercising options for 35,000 shares valued at $69.7K.
Sara B. Capitelli currently holds 35,000 shares of CASI Pharmaceuticals, Inc. (CASI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sara B. Capitelli has been a net neutral trader of CASI stock. They have purchased $0 and sold $0 worth of shares.
Sara B. Capitelli's most recent insider trade was on Jul 12, 2018, when they sold 35,000 shares at $1.99 per share.
Get notified when new Form 4 filings are submitted
| 26,600 |
| $7.49 |
| Discretionary |
| Jul 12, 2018 | CASI | $62.9K | Payment | 8,400 | $7.49 | Discretionary |
| Apr 12, 2018 | CASI | $124.3K | Disposition | 18,778 | $6.62 | Discretionary |
| Apr 12, 2018 | CASI | $54.3K | Payment | 8,200 | $6.62 | Discretionary |
| Apr 12, 2018 | CASI | $23.7K | Option Exercise | 26,978 | $0.88 | Discretionary |